The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Treatment experiences with new agents, including therapy-related decisions and managing side effects
Lizzie Dean
September 4, 2024
During the latest Know AML Ambassador Meeting, Lizzie Dean, a Know AML Ambassador, delivered a patient-led discussion on treatment experiences with new agents, including therapy-related decisions and managing side effects.
Lizzie discusses her experiences and challenges with new acute myeloid leukemia treatment options, including treatment-related decisions, such as evaluating the treatment options, the impact on quality of life, travel costs, and trial withdrawal.
